|
|
|
|
|
| Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | All cause death | stroke (fatal and non fatal) |
|---|
|
| VA drugs, 1968 | niacin | control | | | Low risk of bias | negative | | |
| UCSF SCOR, 1990 | niacin+colestipol | control | | | Exploratory | negative | | |
| Carlson (Stockholm), 1977 | clofibtate+niacin | placebo | secondary prevention | | Risk of bias | suggesting | | |
| CLAS, 1987 | colestipol-niacin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
| CLAS, 1987 | colestipol-niacin | placebo | secondary prevention | | Exploratory | negative | | |
| CDP niacin, 1975 | niacin | placebo | | | Low risk of bias | suggesting | | |
| FATS, 1990 | niacin+colestipol | placebo | | | Low risk of bias | suggesting | | |
| AIM-HIGH, 2011 NCT | niacin | placebo (on top statin) | | | Low risk of bias | negative | | |
| HPS 2-Thrive NCT | niacin | placebo (on top statin) | | | Low risk of bias | negative | | |
| Oxford Niaspan Study, 2009 NCT | niacin | placebo (on top statin) | | | Exploratory | - | | |
| ARBITER 2, 2009 | niacin | placebo (on top statin) | | | Exploratory | negative | | |
| HATS, 2001 | niacin | placebo (on top statin) | | | Low risk of bias | negative | | |
| ARBITER 6-HALTS (niacin vs ezetimibe), 2009 NCT | niacin | ezetimibe | | | Exploratory | suggesting | | |
| Guyton, 2008 | niacin+ezetimibe | simvastatin+ezetimibe | | | Low risk of bias | negative | | |
|
| CLAS, 1987 | colestipol-niacin | placebo | Peripheral Arterial Disease | | Exploratory | - | | |
|
| Carlson (Stockholm), 1977 | clofibtate+niacin | placebo | secondary prevention | | Risk of bias | suggesting | | |
